Pitcher, John D <br/><br/>
A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.  [electronic resource] 

 -  The British journal of ophthalmology  Jun 2015 
 - 848-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2079 
<br/><br/><label>Standard No.: </label>10.1136/bjophthalmol-2014-306018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--therapeutic use<br/>Blood-Retinal Barrier<br/>Capillary Permeability<br/>Central Serous Chorioretinopathy--diagnosis<br/>Chronic Disease<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Prospective Studies<br/>Receptors, Vascular Endothelial Growth Factor--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Subretinal Fluid<br/>Tomography, Optical Coherence<br/>Visual Acuity--physiology